Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75550.42 1090.89 (1.47%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
31	Dr. Agarwals Health Care Ltd.	Q V PT	16,117 Small Cap	513.50 (1.01%)	108.63	7.79	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,422 Small Cap	147.95 (-0.37%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,310 (3.30%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,552 Small Cap	5,309.50 (0.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,881 (-0.80%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Orchid Pharma Ltd.	Q V PT	4,989 Small Cap	849.95 (2.03%)	575.67	3.18	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Gujarat Themis Biosyn Ltd.	Q V PT	4,718 Small Cap	369.80 (2.01%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Sai Parenterals Ltd.	Q V PT	2,302 Small Cap	503.85 (-3.29%)	139.47	2.95	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,187.30 (1.92%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Anlon Healthcare Ltd.	Q V+ PT	1,378 Small Cap	25.03 (-3.43%)	48.32	5.35	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Park Medi World Ltd.	Q V PT	9,513 Small Cap	223.70 (1.57%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	263.40 (2.77%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Medico Remedies Ltd.	Q V+ PT	155 Small Cap	19.24 (3.16%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Senores Pharmaceuticals Ltd.	Q V PT	5,221 Small Cap	1,122.40 (-0.99%)	39.11	5.21	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Aarti Pharmalabs Ltd.	Q V+ PT	7,922 Small Cap	897.20 (2.70%)	32.61	3.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Procter & Gamble Health Ltd.	Q V PT	9,436 Small Cap	5,725 (0.71%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Fortis Healthcare Ltd.	Q V+ PT	58,117 Mid Cap	766.90 (-0.38%)	55.46	5.72	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Take Ltd.	Q V PT	159 Small Cap	10.96 (1.95%)	12.4	4.96	-41.25	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Onesource Specialty Pharma Ltd.	Q V PT	17,926 Small Cap	1,578.70 (0.99%)	N/A	3.03	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Supriya Lifescience Ltd.	Q V+ PT	6,810 Small Cap	841.45 (-0.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Indraprastha Medical Corporation Ltd.	Q V PT	2,797 Small Cap	313.05 (2.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Bajaj Healthcare Ltd.	Q V+ PT	1,031 Small Cap	307.90 (0.57%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Narayana Hrudayalaya Ltd.	Q V PT	35,144 Small Cap	1,840.30 (7.01%)	40.92	7.02	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Dishman Carbogen Amcis Ltd.	Q V+ PT	2,276 Small Cap	149.05 (2.69%)	140.82	0.34	8.93	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Shukra Medtech Ltd.	Q V+ PT	3,317 Small Cap	75.71 (1.01%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,741 Small Cap	175.45 (-0.82%)	3.62	4.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Panacea Biotec Ltd.	Q V PT	1,917 Small Cap	326.75 (4.41%)	N/A	2.29	0.47	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	One Global Service Provider Ltd.	Q V+ PT	854 Small Cap	456.80 (4.50%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Healthcare Global Enterprises Ltd.	Q V+ PT	8,731 Small Cap	581.55 (-0.56%)	522.51	5.42	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Fischer Medical Ventures Ltd.	Q V PT	1,729 Small Cap	25.31 (2.26%)	57.98	3.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,188	-4.60%
Bliss GVS Pharma	623	-3.92%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Anlon Healthcare informs about newspaper advertisement

Anlon Healthcare has informed that it attached copy of Newspaper Advertisement dated October 31, 2026 in Financial Express (English edition) and in Financial Express (Gujarati edition) for publication of copy of extract of Financial Results for the Quarter and Half Year Ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Narayana Hrudayalay. - Quaterly Results

The revenue zoomed 16.31% to Rs. 11853.77 millions for the quarter ended September 2026 as compared to Rs. 10191.69 millions during the corresponding quarter last year.Good Net Profit growth of 27.38% reported above the corresponding previous quarter figure of Rs. 1378.80 millions to Rs. 1756.26 millioins.Operating profit for the quarter ended September 2026 rose to 3045.61 millions as compared to 2461.39 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	11853.77	10191.69	16.31	22824.79	19623.10	16.32	39751.41	35901.22	10.72
Other Income	433.50	170.88	153.69	737.63	335.24	120.03	1764.34	1421.63	24.11
PBIDT	3045.61	2461.39	23.74	5740.96	4415.93	30.01	10158.82	8137.02	24.85
Interest	352.30	285.78	23.28	688.96	592.01	16.38	1271.16	877.08	44.93
PBDT	2693.31	2175.61	23.80	5052.00	3823.92	32.12	8434.90	7259.94	16.18
Depreciation	501.09	462.66	8.31	982.57	938.24	4.72	1914.78	1692.63	13.12
PBT	2192.22	1712.95	27.98	4069.43	2885.68	41.02	6520.12	5567.31	17.11
TAX	435.96	334.15	30.47	934.62	633.17	47.61	1488.99	1255.89	18.56
Deferred Tax	17.03	18.36	-7.24	34.58	30.77	12.38	-75.93	187.21	-140.56
PAT	1756.26	1378.80	27.38	3134.81	2252.51	39.17	5031.13	4311.42	16.69
Equity	2043.61	2043.61	0.00	2043.61	2043.61	0.00	2043.61	2043.61	0.00
PBIDTM(%)	25.69	24.15	6.39	25.15	22.50	11.77	25.56	22.67	12.75

Oct, 2026

OneSource Specialty inches up on getting USFDA’s EIR with VAI classification for Bengaluru SPD facility

The report follows an inspection of the facility conducted from June 22 to June 30, 2026

Oct, 2026

OneSource Specialty gets USFDA’s EIR with VAI classification for Bengaluru SPD facility

The report follows an inspection of the facility conducted from June 22 to June 30, 2026

Oct, 2026

Sanofi India - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4917.00 millions.The Profit for the quarter ended September 2026 of Rs. 1167.00 millions grew by 53.55% from Rs. 760.00 millions.Operating profit for the quarter ended September 2026 rose to 1667.00 millions as compared to 1391.00 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202512	202412	% Var
Sales	4917.00	4754.00	3.43	14017.00	14176.00	-1.12	18374.00	20132.00	-8.73
Other Income	55.00	49.00	12.24	161.00	169.00	-4.73	197.00	165.00	19.39
PBIDT	1667.00	1391.00	19.84	4354.00	4179.00	4.19	5110.00	5073.00	0.73
Interest	2.00	4.00	-50.00	8.00	11.00	-27.27	17.00	15.00	13.33
PBDT	1665.00	1114.00	49.46	4346.00	3895.00	11.58	4820.00	4681.00	2.97
Depreciation	88.00	91.00	-3.30	267.00	278.00	-3.96	373.00	367.00	1.63
PBT	1577.00	1023.00	54.15	4079.00	3617.00	12.77	4447.00	4314.00	3.08
TAX	410.00	263.00	55.89	1051.00	967.00	8.69	1180.00	1177.00	0.25
Deferred Tax	3.00	-49.00	-106.12	4.00	-52.00	-107.69	-49.00	-81.00	-39.51
PAT	1167.00	760.00	53.55	3028.00	2650.00	14.26	3267.00	3137.00	4.14
Equity	230.00	230.00	0.00	230.00	230.00	0.00	230.00	230.00	0.00
PBIDTM(%)	33.90	29.26	15.87	31.06	29.48	5.37	27.81	25.20	10.37

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Indoco Remedies Ltd.	1,923 Crore
2	Piramal Pharma Ltd.	31,826 Crore
3	Sigachi Industries Ltd.	1,009 Crore
4	Solara Active Pharma Sciences Ltd.	3,055 Crore
5	Themis Medicare Ltd.	875 Crore
6	Hikal Ltd.	2,601 Crore
7	Suraksha Diagnostic Ltd.	1,653 Crore
8	Biocon Ltd.	57,365 Crore
9	Cohance Lifesciences Ltd.	17,005 Crore
10	3B Blackbio Dx Ltd.	1,113 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,380	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,668	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,239	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about newspaper publication

Anlon Healthcare informs about newspaper advertisement

Narayana Hrudayalay. - Quaterly Results

OneSource Specialty inches up on getting USFDA’s EIR with VAI classification for Bengaluru SPD facility

OneSource Specialty gets USFDA’s EIR with VAI classification for Bengaluru SPD facility

Sanofi India - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?